MiniMed Group, Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MMED research report →
Range $16 – $29
Price Chart
About the company
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories.
- CEO
- Que Thanh Dallara
- IPO
- 2026
- Employees
- 8,000
- HQ
- Northridge, CA, US
Get TickerSpark's AI analysis on MMED
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.52B
- P/E
- -17.85
- Fwd P/E
- 28.69
- PEG
- 0.11
- P/S
- 1.71
- P/B
- 1.52
- EV/EBITDA
- 60.31
- Div Yield
- 0.00%
- Gross Margin
- 53.85%
- Op Margin
- 0.53%
- Net Margin
- -10.21%
- ROE
- -9.11%
- ROIC
- 0.43%
Latest fiscal year · YoY change
- Revenue
- $3.10B+14.3%
- Gross Profit
- $1.68B+10.2%
- Op Income
- $49.00M
- Net Income
- $-331,000,000-32.4%
- EPS
- $-1.29-44.9%
- OCF Growth
- -240.7%
- FCF Growth
- -692.5%
- 52W High
- $24.43
- 52W Low
- $10.65
- 50D MA
- $20.40
- 200D MA
- $16.35
- Beta
- -3.71
- RSI (14)
- 42
- Avg Volume
- 2.11M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the MMED Q1 '27 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 9.8%
- Shares Outstanding
- 280.84M
- Float Shares
- 27.48M
of shares held by institutions
60 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Massachusetts Financial Services Co | 8.33M | ▲ 1.46M |
| Millennium Management LLC | 3.06M | ▲ 467.18K |
| Citadel Advisors LLC | 2.87M | ▲ 14.16K |
| Longaeva Partners L.P. | 2.81M | ▼ 365.68K |
| Sessa Capital Im, L.P. | 2.00M | 0 |
| Blackrock, Inc. | 2.00M | ▲ 1.97M |
| Norges Bank | 1.96M | ▲ 1.96M |
| Rock Springs Capital Management LP | 1.52M | ▲ 465.00K |
| Exoduspoint Capital Management, LP | 1.44M | ▲ 1.03M |
| Fmr LLC | 1.08M | ▼ 284.31K |
| Geode Capital Management, LLC | 956.02K | ▲ 710.09K |
| Boston Partners | 902.36K | ▲ 57.36K |
Held by 81 ETFs
Biggest fund positions in MMED by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 1, 26 | Denton Sheila A. | other | 58,939 |
| Sep 25, 26 | Denton Sheila A. | other | 0 |
| Jul 31, 26 | Wills Courtney Nelson | other | 1,762 |
| Jul 31, 26 | Dianaty Ali | other | 8,012 |
| Jul 31, 26 | Dallara Que | other | 31,350 |
| Jul 28, 26 | Spooner Chad | other | 23,301 |
| Jul 28, 26 | Chandrasena Gillian | other | 2,099 |
| Mar 25, 26 | Dallara Que | other | 4,809 |
| Mar 11, 26 | Gyurci John | other | 15,322 |
| Mar 11, 26 | Chandrasena Gillian | other | 58,825 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MMED coverage
Recent articles, reports, and earnings notes.
No research on MMED yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MMED report →Why I Think These Are the 2 Smartest Stocks to Buy With $5,000 in October
fool.com · Oct 5
Responding more frequently to MiniMed Smart MDI alerts linked to better glucose outcomes for people with diabetes
prnewswire.com · Oct 5
Why Medtronic's $4 Billion MiniMed Exchange Offer Is Losing Its Allure
barrons.com · Oct 2
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care
zacks.com · Oct 2
MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
prnewswire.com · Sep 28
Squeeze Watch: 10 Stocks With Over 33% Short Interest
benzinga.com · Sep 25
MiniMed Group, Inc. (MMED) Presents at Bank of America Global Healthcare Conference 2026 Transcript
seekingalpha.com · Sep 23
MiniMed Group Inc (NASDAQ:MMED) Receives Consensus Recommendation of “Moderate Buy” from Analysts
defenseworld.net · Sep 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.